The trend: Pressure is growing on drug makers to curb the cost of insulin to diabetes patients.
How we got here: Insulin prices in the US have skyrocketed more than 600% over the last 20 years, per a September 2022 NPR report.
Patients aren’t the only ones concerned about the cost of diabetes treatment. US employers pay approximately $245 billion each year to cover treatment and drugs for diabetic employees, per a study by Nomi Health.
The pressure heats up: Healthcare is already a hot topic in 2023, as the US presidential campaigns get under way. Consumers are paying attention.
Our take: Drug prices are a major concern for Americans, and they’re ready for the government to help.
This article originally appeared in Insider Intelligence's Digital Health Briefing—a daily recap of top stories reshaping the healthcare industry. Subscribe to have more hard-hitting takeaways delivered to your inbox daily.
One Liberty Plaza9th FloorNew York, NY 100061-800-405-0844